Evaluation of Dosing Interval of Higher Doses of Ranibizumab

ClinicalTrials.gov ID: NCT00533520

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00533520. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 1:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluation of Dosing Interval of Higher Doses of Ranibizumab for patients with wet age-related macular degeneration (AMD).

Study identification

NCT ID: NCT00533520
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Brandon G. Busbee, MD; Other
Enrollment: 37 participants

Conditions and interventions

Conditions

Interventions

ranibizumab Drug

Drug

Eligibility (public fields only)

Age range: 50 Years to 95 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2007 (Type not available)
Primary completion: Nov 2013 (Actual)
Completion: Nov 2013 (Actual)
Last update posted: Nov 25, 2013

2007 – 2013

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Tennessee Retina, P.C.	Nashville	Tennessee	37203	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00533520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 25, 2013 · Synced Nov 12, 2026